Classic PE healthcare playbook hitting a wall: governance red flags (board resignations over antitrust violations), Medicaid exposure nobody’s buying their hedge on, and 5x leverage on a home health rollup that can’t get financing done at any price. Market’s saying no for good reason.
When Goldman can’t get your $2.5B home healthcare deal done in this market, and you need to come back with audited financials hoping for better conditions… the market’s already told you everything you need to know.
When Goldman can’t get your $2.5B home healthcare deal done in this market, and you need to come back with audited financials hoping for better conditions… the market’s already told you everything you need to know.